 |
1) Will Tiffany's Earnings Sparkle Like A Diamond? + Vic Wisemann’s Thoughts on TIF, ANF, AEO, JCG, ZLC, M and JCP
Vic Wisemann
Contributor |
|
The economy continues to show signs of recovery while caught in a paradox with consumer confidence heading south. Consumer confidence is a key measure of economic health and also a sound indicator of spending trends. So now, with its thrust in reverse mode, some questions are being thrown towards the level of discretionary spending the economy is anticipating. Investors are also wondering whether discretionary stocks like Tiffany & Co (TIF), Abercrombie & Fitch (ANF), American Eagle Outfitters (AEO) and J. Crew (JCG) are still worthwhile.
Consumer confidence fell in July on concerns about jobs and business conditions, following a sharp decline in June, according to the Conference Board. July's consumer confidence index fell to 50.4, which is the lowest level since February. The figure is down from an upwardly revised 54.3 in June. Concerns about business conditions and the labor market are casting a dark cloud over consumers that is not likely to lift until the job market improves. Given consumers' heightened level of anxiety, along with their pessimistic income outlook and lackluster job growth, retailers are very likely to face a challenging back-to-school season.
|
To Find out more and get answers to the following questions sign up for our
FREE 90 DAY SPECIAL OFFER today.
| • |
Why is Tiffany (TIF) the stock to watch this week? |
| • |
What could a flat economy really mean for Tiffany’s growth plans? |
| • |
What TIF strategy can investors use to target return of almost 128% with over 12% downside protection? |
Stocks Covered: Tiffany (TIF), Abercrombie & Fitch (ANF), American Eagle Outfitters (AEO), J Crew (JCG), Zale (ZLC), Macys (M) and J C Penney (JCP)
Target Returns:Up to 9.1% (127.6%* Annualized) and more
Downside Protection: Up to 12.7% and more
Investor Level: Beginner to Advanced
Risk Level: Moderate Relative Risk
|
| |
|
2) Learn from the Experts |
 |
3) Should You Be Buying Stocks Right Now? |
|
| |
|
In his new report, Forbes columnist Ken Fisher tells you where he thinks the stock market is headed, and why. This must-read report includes proprietary research, and analysis you won’t find anyplace else. Don’t miss it!
Click Here to Download Your Report!
* See Disclaimer Below
|
4) Expert Articles Recap — In Case You Missed It The First Time… |
|
08/12/10 |
|
MarketTaker.com's Dan Passarelli - Reverse Lottery Tickets
Read Story... |
08/12/10 |
|
WealthDaily.com's Ian Cooper - The No-Options Options Trade
Read Story... |
08/12/10 |
|
InvestorsObserver.com's Vic Wisemann - Will Back To School Bring Shoppers Back To Retail? Read Story... |
5) Feature Articles |
|
This Week: What Do Investors Need To Know About Earnings Season Stragglers? Strategies, Tactics, Insights, And Trade Ideas To Play TIF, MDT, and EWC...
- Why is Tiffany (TIF) the stock to watch this week and what strategy can investors use for this stock to target an annualized return of almost 118% with over 12% downside protection?
- Why does S&P give Medtronic (MDT) its highest 5 STARS ranking and what MDT strategy can investors use to target up to a 237% annualized return with just under 5% downside protection?
- Why does Tiffany’s (TIF) juicy dividend make it ripe for a long-term play and what conservative TIF strategy can investors use to target an annualized return of almost 22% with over 12% downside protection and a 2.36% dividend?
- Why should investors diversify their portfolios with a Canadian ETF and which hedged ETF strategy can generate a targeted annualized return of up to 13% with over 10% downside protection and a generous 1.63% dividend?
Get this week’s feature articles by our portfolio analysts. Expect the options and hedge strategies, tactics, insights, and specific trade ideas that could give you an inside edge. This weeks articles are titled:
Stocks Covered: Tiffany & Co. (TIF), Medtronic (MDT)
Target Returns: Up to 9.9% or 128.9% Annualized*
Downside Protection: Up to 12.8%
Investor Level: Beginner to Advanced
Risk Level: Low to Moderate Relative Risk
6) InvestorsKeyhole Market Information |
|
Get today’s breaking news and tips from a network of floor traders, company executives, experts, analysts and timely information resources. This service has had over an 89% success rate over the last 5 years.
Stock Covered: Hewlett-Packard Company (HPQ)
Target Return: 12.4 and 51.4% Annualized*
Downside Protection: Up to 11.7%
Investor Level: Beginner to Advanced
7) Portfolio Update: Conservative Covered Call Plus portfolio |
|
Expiration is past us and several of our sold calls expired worthless last week. This week, our analysts will look to sell follow-on trades, which will bring in some cash and lower our amount at risk. Also this week, we should have new trades posted in the September-month portfolio. This service points out a series of covered call trades along with a companion series of hedged trades using the same underlying stocks requiring much less capital. These are hedged investments so returns are protected even if the stock drops in price. Get a rebate if you sign up for this service today.
Stocks Covered: Bristol-Myers Squibb (BMY) and Ingersoll-Rand (IR)
Target Returns: $1,689 or 5.5%
Investor Level: Beginner to Advanced
Risk Level: Moderate Relative Risk
8) Exclusive Special Report! Can One Drug Change an Entire Industry? |
|
Be one of the first to read and reap from this options trade based report.
Summary: The pharmaceutical industry is constantly trying to adapt to pressures from legislation, patent expirations, and the FDA. In recent years, the trend has been to invest time and money into biologics, which is more expensive, but not as easily copied as the traditional small molecule drugs. This article will discuss several key players in big pharma and how the trend towards biologics has positioned them within the industry.
Stocks Covered: Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), Pfizer, Inc. (PFE), Bristol Myers Squibb (BMY), Merck & Co., Inc. (MRK)
Target Returns: Up to 25.0% or 86.1% Annualized*
Downside Protection: Up to 8.6%
Investor Level: Beginner to Advanced
Risk Level: Moderate Relative Risk
All stocks and options shown are examples only. These are not recommendations to buy or sell any security. Any pricing or potential profitability shown does not take into account your trade size, brokerage commissions or taxes which will affect actual investment returns. Annualized returns are shown to assist in comparing investment of different durations only. Stocks and options involve risk and are not suitable for all investors and investing in options carries substantial risk. Prior to buying or selling options, a person must receive a copy of Characteristics and Risks of Standardized Options available at: http://www.cboe.com/Resources/Intro.aspx. Stock recommendations and comments presented are solely those of the analysts, experts, or information source quoted. They do not represent the opinions of Investors Observer or InvestorsKeyhole on whether to buy, sell or hold shares of a particular stock or option. Investors should be cautious about any and all stock or option recommendations and should consider the source of any advice on stock or option selection. Various factors, including personal or corporate ownership, may influence or factor into an expert's stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock or option performance is no guarantee of future price appreciation or depreciation. Those involved with the preparation and distribution of this report may have had in the past, currently hold, or may purchase in the future stock and/or options in companies discussed in this report. It is expected that the limited distribution of this report to a relatively small number of investor will not materially affect the price of this widely held stock.
*InvestorsObserver Disclaimer
This is is a paid advertisement provided to our patrons. Although we have sent you this e-mail, InvestorsObserver.com does not endorse this product nor is it responsible for the content of this ad. Furthermore, we make no guarantee or warranty about what is advertised above.
_________________________________
Janet Preston - Director of Pull-It-All-Together
InvestorsObserver.com
Better Strategies for Making Money
For Investors With a Sense of Humor
534 E. Main Street, Suite D
Charlottesville, VA 22902
If you do not want to receive these e-mailings from InvestorsObserver.com, please follow these steps:
WARNING: This WILL NOT cancel your PAID subscription.
This link will only stop the emails you receive as a paying subscriber.
* If you wish to cancel your services, go to the help section of: InvestorsObserver.com
* If you wish to stop the mailings only...
1) Go to: http://www.investorsobserver.com/opt_out.asp?f=nr
2) Enter the email address that receives our mailings.
3) Click on the REMOVE ME button.
RESULTS: That email address will be removed within 1 week.
CAUTION: Replying to this email will NOT take you off our mailing list.
InvestorsObserver.com | Complimentary Offer |About Us
Send to a Friend | 90 Day Free Trial |
|
